Building on our prior findings that Nok activates AMPK in MAFLD, this study confirmed that Nok’s effects on T2DM are likely mediated through AMPK activation, supporting its potential as a multi-functional therapeutic approach. The gene discussed is STYK1; the disease is type 2 diabetes mellitus.